血清SOX6、VCAN表达对胃癌诊断及病情评估的价值分析

黄小平; 李轶; 李萍

doi:10.11659/jjssx.01E023098

您当前的位置：

首页 >

文章列表页 >

血清SOX6、VCAN表达对胃癌诊断及病情评估的价值分析

临床研究 | 更新时间：2024-02-02

- 血清SOX6、VCAN表达对胃癌诊断及病情评估的价值分析
- Value of the expression of serum SOX6 and VCAN in the diagnosis and condition evaluation of gastric cancer
- 局解手术学杂志 2024年33卷第2期页码：149-152
- 作者机构：
  
  1.西安市第九医院消化内科，陕西西安 710054
  2.西安市第九医院血管介入科，陕西西安 710054
- 作者简介：
  
  李萍，E-mail：vlqmtui593306@163.com
- 基金信息：
  
  西安市第九医院科研项目(2020-7)
- DOI：10.11659/jjssx.01E023098
  中图分类号： R735.2
- 纸质出版日期：2024-02-25，
  
  收稿日期：2023-01-30，
扫描看全文
黄小平,李轶,李萍.血清SOX6、VCAN表达对胃癌诊断及病情评估的价值分析[J].局解手术学杂志,2024,33(02):149-152.

.Value of the expression of serum SOX6 and VCAN in the diagnosis and condition evaluation of gastric cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(02):149-152.
黄小平,李轶,李萍.血清SOX6、VCAN表达对胃癌诊断及病情评估的价值分析[J].局解手术学杂志,2024,33(02):149-152. DOI： 10.11659/jjssx.01E023098.

.Value of the expression of serum SOX6 and VCAN in the diagnosis and condition evaluation of gastric cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(02):149-152. DOI： 10.11659/jjssx.01E023098.

摘要

目的

探讨胃癌患者血清中性别决定区Y框蛋白6（SOX6）、多功能蛋白聚糖（VCAN）的表达情况，并分析其对胃癌患者诊断及病情评估的价值。

方法

选取2019年1月至2021年10月本院收治的胃癌患者105例为胃癌组，依据病理分期将患者分为Ⅰ、Ⅱ期组（37例）和Ⅲ、Ⅳ期组（68例）；另选取本院收治的胃良性病变患者85例为良性组；同时选取85例健康体检者为对照组。采用实时qRT-PCR法对血清中SOX6、VCAN mRNA表达水平进行检测，采用

Spearman

法分析SOX6、VCAN表达与病理分期的相关性；受试者工作特征（

ROC

）曲线评价血清SOX6、VCAN表达对胃癌的诊断价值。

结果

胃癌组患者血清中SOX6表达水平低于对照组和良性组，VCAN表达水平高于对照组和良性组，差异均有统计学意义（

0.05）。胃癌Ⅲ、Ⅳ期组患者血清中VCAN表达水平高于Ⅰ、Ⅱ期组患者，SOX6表达水平低于Ⅰ、Ⅱ期组患者，差异均有统计学意义（

0.05）。相关性分析结果显示，胃癌患者血清中SOX6表达与病理分期呈负相关（

=-0.485，

0.05），VCAN表达与病理分期呈正相关（

=0.518，

0.05）。

ROC

曲线结果显示，SOX6、VCAN预测胃癌患者的曲线下面积（

AUC

）分别为0.921（95%

：0.873~0.955）、0.915（95%

：0.865~0.950），敏感度分别为92.38%、79.05%，特异度分别为83.53%、95.29%；二者联合诊断胃癌患者的

AUC

为0.969（95%

：0.934~0.989），敏感度为94.29%，特异度为90.59%。

结论

胃癌患者血清中SOX6表达水平降低，VCAN表达水平升高，二者联合检测可作为胃癌诊断的血清标志物，同时可间接预测胃癌病情程度。

Abstract

Objective

To investigate the expression of serum sex determining region Y-box 6 （SOX6） and versican （VCAN） in patients with gastric cancer， and to analyze their value in the diagnosis and condition evaluation of patients with gastric cancer.

Methods

A total of 105 patients with gastric cancer admitted to our hospital from January 2019 to October 2021 were selected as the gastric cancer group， and they were divided into stage Ⅰ and Ⅱ group （37 cases） and stage Ⅲ and Ⅳ group （68 cases） according to pathological stages； 85 patients with benign gastric lesions admitted to our hospital were selected as the benign group， and 85 healthy people were selected as the control group. The expression levels of serum SOX6 and VCAN mRNA were detected by qRT-PCR， the correlation between SOX6 and VCAN expression and pathological stage was analyzed by

Spearman

method.

Receiver operating characteristic

（

ROC

） curve was used to evaluate the diagnostic value of serum SOX6 and VCAN expression for gastric cancer.

Results

The expression level of serum SOX6 in gastric cancer group was lower than those in the control group and the benign group， and the expression level of VCAN was higher than those in the control group and the benign group， with statistical significance （

0.05）. The expression level of serum VCAN of patients with gastric cancer in stage Ⅲ and Ⅳ group was higher than that in stage Ⅰ and Ⅱ group， and the expression level of SOX6 was lower than that in stage Ⅰ and Ⅱ group， with statistical significance （

0.05）. The results of correlation analysis showed that the expression of serum SOX6 in patients with gastric cancer was negatively correlated with pathological stage （

=-0.485，

0.05）， and the expression of VCAN was positively correlated with the pathological stage （

=0.518，

0.05）. The results of

ROC

curve showed that

the area under the curve

（

AUC

） of SOX6 and VCAN in predicting patients with gastric cancer were 0.921 （95%

：0.873 to 0.955） and 0.915 （95%

：0.865 to 0.950）， respectively， the sensitivity were 92.38% and 79.05%， respectively， the specificity were 83.53% and 95.29%， respectively； the

AUC

of the combined diagnosis of SOX6 and VCAN for patients with gastric cancer was 0.969 （95%

：0.934 to 0.989）， the sensitivity was 94.29%， and the specificity was 90.59%.

Conclusion

The expression level of serum SOX6 in patients with gastric cancer is decreased， and the expression level of VCAN is increased. The combined detection of SOX6 and VCAN can be used as serum markers for the diagnosis of gastric cancer， and can indirectly predict the condition severity of gastric cancer.

关键词

胃癌性别决定区Y框蛋白6多功能蛋白聚糖相关性

Keywords

gastric cancersex determining region Y-box 6versicancorrelation

references

Norwood DA，Montalvan-Sanchez E，Dominguez RL，et al.Gastric cancer：emerging trends in prevention，diagnosis，and treatment［J］.Gastroenterol Clin North Am，2022，51（3）：501-518.doi：10.1016/j.gtc.2022.05.001http://dx.doi.org/10.1016/j.gtc.2022.05.001.

周真真，曾俊涛，卓恩挺，等.血清P53、可溶性自杀因子蛋白对海南黎族胃癌患者的诊断及其在病情评估中的价值研究［J］.临床内科杂志，2020，37（4）：291-293.doi：10.3969/j.issn.1001-9057. 2020.04.014http://dx.doi.org/10.3969/j.issn.1001-9057.2020.04.014.

Liu Q，Zhang Y，Zhang J，et al.Inverse correlation between Interleukin-34 and gastric cancer，a potential biomarker for prognosis［J］.Cell Biosci，2020，10（1）：94.doi：10.1186/s13578-020-00454-8.doi：10.1186/s13578-020-00454-8http://dx.doi.org/10.1186/s13578-020-00454-8.doi：10.1186/s13578-020-00454-8.

Zhou Q，Li H，Jing J，et al.Evaluation of C5orf66-AS1 as a potential biomarker for predicting early gastric cancer and its role in gastric carcinogenesis［J］.Onco Targets Ther，2020，13：2795-2805.doi：10.2147/OTT.S239965http://dx.doi.org/10.2147/OTT.S239965.

郑庆蕊，周美云，韩影影，等.SOX6在口腔黏液表皮样癌中的表达及其临床意义［J］.中华全科医学，2021，19（3）：402-440.doi：10.16766/j.cnki.issn.1674-4152.001821http://dx.doi.org/10.16766/j.cnki.issn.1674-4152.001821

Chapel DB，Hirsch MS.SOX6 expression is sensitive for peritoneal

epithelioid malignant mesothelioma，but not specific in the differential diagnosis with tubo-ovarian serous neoplasia［J］.Am J Surg Pathol，2022，46（2）：213-219.doi：10.1097/PAS.0000000000001792http://dx.doi.org/10.1097/PAS.0000000000001792.

Dang Y，Liu T，Yan J，et al.Gastric cancer proliferation and invasion is reduced by macrocalyxin C via activation of the miR-212-3p/SOX6 Pathway［J］.Cell Signal，2020，85：109430.doi：10.1016/j.cellsig. 2019.109430http://dx.doi.org/10.1016/j.cellsig.2019.109430.

刘易陇，覃小貌，郑卓婷，等.VCAN在胃癌中的表达及预后价值研究［J］.四川医学，2019，40（11）：1085-1089.doi：10.16252/j.cnki.issn1004-0501-2019.11.001http://dx.doi.org/10.16252/j.cnki.issn1004-0501-2019.11.001.

克里斯坦·维特金德，浅村尚生，莱斯利·索宾.恶性肿瘤TNM分期图谱［M］.天津：天津科技翻译出版有限公司，2015：68-73.

中华人民共和国国家卫生和计划生育委员会.胃癌规范化诊疗指南（试行）［J］.中国医学前沿杂志（电子版），2013（8）：56-63.doi：10.3969/j.issn.1674-7372.2013.08.012http://dx.doi.org/10.3969/j.issn.1674-7372.2013.08.012.

Zhang Y，Yu J.The role of MRI in the diagnosis and treatment of gastric cancer［J］.Diagn Interv Radiol，2020，26（3）：176-182.doi：10.5152/dir.2019.19375http://dx.doi.org/10.5152/dir.2019.19375.

杨俭，薛辉，穆素恩，等.微小RNA-26a在胃癌患者血清中的表达及其对该病的诊断价值［J］.中国医药，2020，15（10）：1572-1575.doi：10.3760/j.issn.1673-4777.2020.10.020http://dx.doi.org/10.3760/j.issn.1673-4777.2020.10.020.

张乙川，李玲，杨成俊，等.miR-3607在胃癌中的表达及其与预后的相关性研究［J］.局解手术学杂志，2021，30（12）：1025-1029.doi：10.11659/jjssx.06E021132http://dx.doi.org/10.11659/jjssx.06E021132.

Lv L，Zhou M，Zhang J，et al.SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53，p21CIPI，cyclin D1 and β-catenin［J］.FEBS Open Bio，2020，10（1）：135-146.doi：10.1002/2211-5463http://dx.doi.org/10.1002/2211-5463.

付真睿，盛飞，张昌文，等.SOX6在膀胱癌发生发展中的作用及相关机制［J］.天津医科大学学报，2019，25（4）：373-377.

黄伟钊，吴颖猛，胡荣贵，等.食管癌组织中miR-1269a、SOX6的表达变化及意义［J］.山东医药，2020，60（19）：9-12.doi：10.3969/j.issn.1002-266X.2020.19.003http://dx.doi.org/10.3969/j.issn.1002-266X.2020.19.003.

吴娅琦，罗璐遥，唐亚男，等.多功能蛋白聚糖及其相关分子在多发性骨髓瘤患者中的表达及其临床意义［J］.中国实验血液学杂志，2020，28（4）：1228-1233.doi：10.19746/j.cnki.issn1009-2137. 2020.04.024http://dx.doi.org/10.19746/j.cnki.issn1009-2137.2020.04.024.

Li W，Han F，Fu M，et al.High expression of VCAN is an independent predictor of poor prognosis in gastric cancer［J］.J Int Med Res，2020，48（1）：300060519891271.doi：10.1177/0300060519891271http://dx.doi.org/10.1177/0300060519891271.

Zhai L，Chen W，Cui B，et al.Overexpressed versican promoted cell multiplication，migration and invasion in gastric cancer［J］.Tissue Cell，2021，73：101611.doi：10.1016/j.tice.2021.101611http://dx.doi.org/10.1016/j.tice.2021.101611.

张捷，龚庆豪，章波，等.多功能蛋白聚糖在胃癌中的表达及其临床预后［J］.安徽医药，2020，24（9）：1798-1803.doi：10.3969/j.issn.1009-6469.2020.09.026http://dx.doi.org/10.3969/j.issn.1009-6469.2020.09.026.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

血清COL1A1/2表达与颅内动脉瘤破裂的相关性研究

M2型肿瘤相关巨噬细胞参与胃癌细胞转移及免疫逃逸的机制研究

胃癌血清miR-375和CHSY1表达与幽门螺杆菌感染的相关性研究

过表达CBX7调控PTEN/Akt信号通路干预上皮-间充质转化抑制胃癌细胞迁移、侵袭

微创远端胃癌手术结合D2淋巴结清扫治疗胃癌的临床疗效分析